Checkpoint inhibitors: What gastroenterologists need to know.

Authors

Monjur Ahmed, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

12-28-2018

Comments

This article has been peer reviewed. It is the author’s final published version in World Journal of Gastroenterology, Volume 24, Issue 48, December 2018, Pages 5433-5438.

The published version is available at https://doi.org/10.3748/wjg.v24.i48.5433. Copyright © Ahmed

Abstract

Checkpoint inhibitors are increasingly being used in clinical practice. They can cause various gastrointestinal, hepatic and pancreatic side effects. As these side effects can be serious, appropriate management is essential. The different checkpoint inhibitors with their mechanisms of action and indications, as well as evaluation and management of gastrointestinal, hepatic and pancreatic side effects, are discussed in this article.

Recommended Citation

Ahmed, Monjur, "Checkpoint inhibitors: What gastroenterologists need to know." (2018). Division of Gastroenterology and Hepatology Faculty Papers. Paper 54.
https://jdc.jefferson.edu/gastro_hepfp/54

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

PubMed ID

30622372

Language

English